BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 11 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 12 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 12 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 13 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 13 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 14 hours ago Atmus Welcomes Heath Sharp to Board of Directors 16 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 16 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 3 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 3 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 11 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 12 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 12 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 13 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 13 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 14 hours ago Atmus Welcomes Heath Sharp to Board of Directors 16 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 16 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 3 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 3 days ago
ADVERTISEMENT
Market News

Cronos (CRON) Q2 Earnings: Key financials and quarterly highlights

Cronos Group Inc. (NASDAQ: CRON) reported second quarter 2020 earnings results today. Consolidated net revenues grew 29% year-over-year to $9.9 million, driven by continued growth in the adult-use Canadian cannabis market, sales from cannabis vaporizers and the Redwood acquisition. Net loss amounted to $107.7 million, or $0.31 per share, compared to a net income of […]

$CRON August 6, 2020 1 min read

Cronos Group Inc. (NASDAQ: CRON) reported second quarter 2020 earnings results today.

Consolidated net revenues grew 29% year-over-year to $9.9 million, driven by continued growth in the adult-use Canadian cannabis market, sales from cannabis vaporizers and the Redwood acquisition.

Net loss amounted to $107.7 million, or $0.31 per share, compared to a net income of $185 million, or $0.16 per share.

During the second quarter, the company’s revenue growth rate in the US segment was materially impacted by COVID-19, as a significant number of retail customers experienced store closures, which hurt sales and demand.

ADVERTISEMENT